Microbiome-Based Tailored IBD Interventions for More Efficacious Therapy

Time: 4:00 pm
day: Conference Day One


  • Overview of defined bacterial consortia as a microbiome therapeutic
  • Role for the microbiome in IBD
  • Overview of VE202 and preclinical work in IBD
  • Considering the need for personalised medicine – can we target multiple mechanisms simultaneously by harnessing the microbiome?